With more injectable options available than ever, choosing between them can feel overwhelming. Two of the newer names in the neuromodulator space — Jeuveau® and Daxxify® — are both offered at Estetica Medical Aesthetics in Hamilton, NJ, and each has distinct qualities worth understanding before you book.
Both Jeuveau and Daxxify are botulinum toxin type A formulations that work by temporarily relaxing the facial muscles responsible for dynamic wrinkles, like frown lines and crow’s feet. Both are FDA-approved, administered via quick in-office injections, and require little to no downtime.
Jeuveau uses Hi-Pure™ manufacturing technology to isolate the core toxin. Daxxify uses a peptide-based stabilizer (Peptide Exchange Technology) instead of the human serum albumin found in most other neuromodulators — a genuinely novel approach in this category.
This is often the deciding factor for patients. Jeuveau’s results typically last 3–4 months, similar to Botox. Daxxify has shown potential for longer-lasting results — often 4–6 months, and up to 9 months for some patients in clinical trials — meaning fewer appointments per year for many people.
Both formulations tend to show visible results within a few days, with full effect typically settling in around the two-week mark. Individual onset time can vary.
Ultimately, the right choice depends on your muscle strength, treatment area, budget, and personal preference — not just brand name. During your consultation at Estetica, we’ll help you weigh these factors honestly, without steering you toward one option just because it’s newer or trendier.
Book a consultation to talk through which option best fits your goals and lifestyle.
Book a consultation and we’ll help you decide between Jeuveau, Daxxify, and Botox based on your goals.